Table 4.
PFS according to baseline characteristics.
| No. of Patients (%) | Median PFS (months) | HR (95%CI) | |
|---|---|---|---|
| Age group | |||
| <65 years | 27 (67.5%) | 7.90 | 0.98 (0.94-1.03) |
| ≥65 years | 13 (32.5%) | 10.30 | |
| Sex | |||
| Female | 1 (2.5%) | Undefined | Undefined |
| Male | 39 (97.5%) | 8.60 | |
| Smoking status | |||
| Never smoked | 3 (7.5%) | 11.60 | 1.61 (0.80-3.24) |
| Current smoker | 32 (80%) | 6.80 | |
| Former smoker | 5 (12.5%) | 11.70 | |
| Disease stage | |||
| III | 9 (22.5%) | 9.40 | 1.596 (0.66-3.89) |
| IV | 31 (77.5%) | 7.90 | |
| ECOG score | |||
| 0 | 7 (17.5%) | 7.40 | 1.041 (0.40-2.71) |
| 1 | 33 (82.5%) | 8.70 | |
| Brain metastasis at enrollment | |||
| YES | 3 (7.5%) | 6.67 | 2.66 (0.28-24.97) |
| NO | 37 (92.5%) | 8.63 | |
| Liver metastases at enrollment | |||
| YES | 6 (15%) | 6.70 | 1.69 (0.53-5.42) |
| NO | 34 (85%) | 9.37 | |